Report Detail

Pharma & Healthcare Global Cancer Drugs Market Insights, Forecast to 2025

  • RnM2389936
  • |
  • 14 June, 2019
  • |
  • Global
  • |
  • 116 pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Global Cancer Drugs Market Insights, Forecast to 2025

Table of Contents

    1 Study Coverage

    • 1.1 Cancer Drugs Product
    • 1.2 Market Segments
    • 1.3 Key Manufacturers Covered
    • 1.4 Market by Type
      • 1.4.1 Global Cancer Drugs Market Size Growth Rate by Product
      • 1.4.2 Breast Cancer
      • 1.4.3 Blood Cancer
      • 1.4.4 Gastrointestinal Cancer
      • 1.4.5 Prostate Cancer
      • 1.4.6 Skin Cancer
      • 1.4.7 Lung Cancer
      • 1.4.8 Others
    • 1.5 Market by End User
      • 1.5.1 Global Cancer Drugs Market Size Growth Rate by End User
      • 1.5.2 Immunotherapy
      • 1.5.3 Targeted Therapy
      • 1.5.4 Chemotherapy
      • 1.5.5 Hormone Therapy
      • 1.5.6 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Executive Summary

    • 2.1 Global Cancer Drugs Market Size
      • 2.1.1 Global Cancer Drugs Revenue 2014-2025
      • 2.1.2 Global Cancer Drugs Sales 2014-2025
    • 2.2 Cancer Drugs Growth Rate by Regions
      • 2.2.1 Global Cancer Drugs Sales by Regions
      • 2.2.2 Global Cancer Drugs Revenue by Regions

    3 Breakdown Data by Manufacturers

    • 3.1 Cancer Drugs Sales by Manufacturers
      • 3.1.1 Cancer Drugs Sales by Manufacturers
      • 3.1.2 Cancer Drugs Sales Market Share by Manufacturers
      • 3.1.3 Global Cancer Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.2 Cancer Drugs Revenue by Manufacturers
      • 3.2.1 Cancer Drugs Revenue by Manufacturers (2014-2019)
      • 3.2.2 Cancer Drugs Revenue Share by Manufacturers (2014-2019)
    • 3.3 Cancer Drugs Price by Manufacturers
    • 3.4 Cancer Drugs Manufacturing Base Distribution, Product Types
      • 3.4.1 Cancer Drugs Manufacturers Manufacturing Base Distribution, Headquarters
      • 3.4.2 Manufacturers Cancer Drugs Product Type
      • 3.4.3 Date of International Manufacturers Enter into Cancer Drugs Market
    • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Product

    • 4.1 Global Cancer Drugs Sales by Product
    • 4.2 Global Cancer Drugs Revenue by Product
    • 4.3 Cancer Drugs Price by Product

    5 Breakdown Data by End User

    • 5.1 Overview
    • 5.2 Global Cancer Drugs Breakdown Data by End User

    6 North America

    • 6.1 North America Cancer Drugs by Countries
      • 6.1.1 North America Cancer Drugs Sales by Countries
      • 6.1.2 North America Cancer Drugs Revenue by Countries
      • 6.1.3 United States
      • 6.1.4 Canada
      • 6.1.5 Mexico
    • 6.2 North America Cancer Drugs by Product
    • 6.3 North America Cancer Drugs by End User

    7 Europe

    • 7.1 Europe Cancer Drugs by Countries
      • 7.1.1 Europe Cancer Drugs Sales by Countries
      • 7.1.2 Europe Cancer Drugs Revenue by Countries
      • 7.1.3 Germany
      • 7.1.4 France
      • 7.1.5 UK
      • 7.1.6 Italy
      • 7.1.7 Russia
    • 7.2 Europe Cancer Drugs by Product
    • 7.3 Europe Cancer Drugs by End User

    8 Asia Pacific

    • 8.1 Asia Pacific Cancer Drugs by Countries
      • 8.1.1 Asia Pacific Cancer Drugs Sales by Countries
      • 8.1.2 Asia Pacific Cancer Drugs Revenue by Countries
      • 8.1.3 China
      • 8.1.4 Japan
      • 8.1.5 Korea
      • 8.1.6 India
      • 8.1.7 Australia
      • 8.1.8 Indonesia
      • 8.1.9 Malaysia
      • 8.1.10 Philippines
      • 8.1.11 Thailand
      • 8.1.12 Vietnam
      • 8.1.13 Singapore
    • 8.2 Asia Pacific Cancer Drugs by Product
    • 8.3 Asia Pacific Cancer Drugs by End User

    9 Central & South America

    • 9.1 Central & South America Cancer Drugs by Countries
      • 9.1.1 Central & South America Cancer Drugs Sales by Countries
      • 9.1.2 Central & South America Cancer Drugs Revenue by Countries
      • 9.1.3 Brazil
    • 9.2 Central & South America Cancer Drugs by Product
    • 9.3 Central & South America Cancer Drugs by End User

    10 Middle East and Africa

    • 10.1 Middle East and Africa Cancer Drugs by Countries
      • 10.1.1 Middle East and Africa Cancer Drugs Sales by Countries
      • 10.1.2 Middle East and Africa Cancer Drugs Revenue by Countries
      • 10.1.3 GCC Countries
      • 10.1.4 Turkey
      • 10.1.5 Egypt
      • 10.1.6 South Africa
    • 10.2 Middle East and Africa Cancer Drugs by Product
    • 10.3 Middle East and Africa Cancer Drugs by End User

    11 Company Profiles

    • 11.1 Bayer
      • 11.1.1 Bayer Company Details
      • 11.1.2 Company Business Overview
      • 11.1.3 Bayer Cancer Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.1.4 Bayer Cancer Drugs Products Offered
      • 11.1.5 Bayer Recent Development
    • 11.2 GlaxoSmithKline
      • 11.2.1 GlaxoSmithKline Company Details
      • 11.2.2 Company Business Overview
      • 11.2.3 GlaxoSmithKline Cancer Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.2.4 GlaxoSmithKline Cancer Drugs Products Offered
      • 11.2.5 GlaxoSmithKline Recent Development
    • 11.3 Novartis
      • 11.3.1 Novartis Company Details
      • 11.3.2 Company Business Overview
      • 11.3.3 Novartis Cancer Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.3.4 Novartis Cancer Drugs Products Offered
      • 11.3.5 Novartis Recent Development
    • 11.4 Sanofi and Pfizer
      • 11.4.1 Sanofi and Pfizer Company Details
      • 11.4.2 Company Business Overview
      • 11.4.3 Sanofi and Pfizer Cancer Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.4.4 Sanofi and Pfizer Cancer Drugs Products Offered
      • 11.4.5 Sanofi and Pfizer Recent Development
    • 11.5 Amgen
      • 11.5.1 Amgen Company Details
      • 11.5.2 Company Business Overview
      • 11.5.3 Amgen Cancer Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.5.4 Amgen Cancer Drugs Products Offered
      • 11.5.5 Amgen Recent Development
    • 11.6 Merck
      • 11.6.1 Merck Company Details
      • 11.6.2 Company Business Overview
      • 11.6.3 Merck Cancer Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.6.4 Merck Cancer Drugs Products Offered
      • 11.6.5 Merck Recent Development
    • 11.7 Bristol-Myers Squibb
      • 11.7.1 Bristol-Myers Squibb Company Details
      • 11.7.2 Company Business Overview
      • 11.7.3 Bristol-Myers Squibb Cancer Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.7.4 Bristol-Myers Squibb Cancer Drugs Products Offered
      • 11.7.5 Bristol-Myers Squibb Recent Development
    • 11.8 Celgene Corporation
      • 11.8.1 Celgene Corporation Company Details
      • 11.8.2 Company Business Overview
      • 11.8.3 Celgene Corporation Cancer Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.8.4 Celgene Corporation Cancer Drugs Products Offered
      • 11.8.5 Celgene Corporation Recent Development
    • 11.9 Ariad Pharmaceuticals
      • 11.9.1 Ariad Pharmaceuticals Company Details
      • 11.9.2 Company Business Overview
      • 11.9.3 Ariad Pharmaceuticals Cancer Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.9.4 Ariad Pharmaceuticals Cancer Drugs Products Offered
      • 11.9.5 Ariad Pharmaceuticals Recent Development
    • 11.10 Eli Lilly
      • 11.10.1 Eli Lilly Company Details
      • 11.10.2 Company Business Overview
      • 11.10.3 Eli Lilly Cancer Drugs Sales, Revenue and Gross Margin (2014-2019)
      • 11.10.4 Eli Lilly Cancer Drugs Products Offered
      • 11.10.5 Eli Lilly Recent Development
    • 11.11 Hoffmann-La Roche
    • 11.12 Boehringer Ingelheim
    • 11.13 Johnson and Johnson
    • 11.14 Teva Pharmaceuticals

    12 Future Forecast

    • 12.1 Cancer Drugs Market Forecast by Regions
      • 12.1.1 Global Cancer Drugs Sales Forecast by Regions 2019-2025
      • 12.1.2 Global Cancer Drugs Revenue Forecast by Regions 2019-2025
    • 12.2 Cancer Drugs Market Forecast by Product
      • 12.2.1 Global Cancer Drugs Sales Forecast by Product 2019-2025
      • 12.2.2 Global Cancer Drugs Revenue Forecast by Product 2019-2025
    • 12.3 Cancer Drugs Market Forecast by End User
    • 12.4 North America Cancer Drugs Forecast
    • 12.5 Europe Cancer Drugs Forecast
    • 12.6 Asia Pacific Cancer Drugs Forecast
    • 12.7 Central & South America Cancer Drugs Forecast
    • 12.8 Middle East and Africa Cancer Drugs Forecast

    13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    • 13.1 Market Opportunities and Drivers
    • 13.2 Market Challenges
    • 13.3 Market Risks/Restraints
    • 13.4 Macroscopic Indicators

    14 Value Chain and Sales Channels Analysis

    • 14.1 Value Chain Analysis
    • 14.2 Cancer Drugs Customers
    • 14.3 Sales Channels Analysis
      • 14.3.1 Sales Channels
      • 14.3.2 Distributors

    15 Research Findings and Conclusion

      16 Appendix

      • 16.1 Research Methodology
        • 16.1.1 Methodology/Research Approach
        • 16.1.2 Data Source
      • 16.2 Author Details

      It is used in the treatment of cancer.
      The global Cancer Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Cancer Drugs market based on company, product type, end user and key regions.

      This report studies the global market size of Cancer Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Cancer Drugs in these regions.
      This research report categorizes the global Cancer Drugs market by top players/brands, region, type and end user. This report also studies the global Cancer Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

      The following manufacturers are covered in this report, with sales, revenue, market share for each company:
      Bayer
      GlaxoSmithKline
      Novartis
      Sanofi and Pfizer
      Amgen
      Merck
      Bristol-Myers Squibb
      Celgene Corporation
      Ariad Pharmaceuticals
      Eli Lilly
      Hoffmann-La Roche
      Boehringer Ingelheim
      Johnson and Johnson
      Teva Pharmaceuticals

      Market size by Product
      Breast Cancer
      Blood Cancer
      Gastrointestinal Cancer
      Prostate Cancer
      Skin Cancer
      Lung Cancer
      Others
      Market size by End User
      Immunotherapy
      Targeted Therapy
      Chemotherapy
      Hormone Therapy
      Others

      Market size by Region
      North America
      United States
      Canada
      Mexico
      Asia-Pacific
      China
      India
      Japan
      South Korea
      Australia
      Indonesia
      Singapore
      Malaysia
      Philippines
      Thailand
      Vietnam
      Europe
      Germany
      France
      UK
      Italy
      Spain
      Russia
      Central & South America
      Brazil
      Rest of Central & South America
      Middle East & Africa
      GCC Countries
      Turkey
      Egypt
      South Africa

      The study objectives of this report are:
      To study and analyze the global Cancer Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
      To understand the structure of Cancer Drugs market by identifying its various subsegments.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      Focuses on the key global Cancer Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
      To project the value and sales volume of Cancer Drugs submarkets, with respect to key regions.
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

      In this study, the years considered to estimate the market size of Cancer Drugs are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Cancer Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.


      Summary:
      Get latest Market Research Reports on Cancer Drugs . Industry analysis & Market Report on Cancer Drugs is a syndicated market report, published as Global Cancer Drugs Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Cancer Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,900.00
      $5,850.00
      $7,800.00
      3,099.86
      4,649.80
      6,199.73
      3,475.07
      5,212.61
      6,950.14
      423,395.70
      635,093.55
      846,791.40
      272,483.25
      408,724.88
      544,966.50
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report